Home › NDC Lookup › RxCUI directory › RxCUI 2708837

Revakinagene taroretcel-lwey 440000 CELLS Drug Implant — RxCUI 2708837

RxNorm drug concept · Semantic clinical drug
RxCUI 2708837 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2708837
Official nameRevakinagene taroretcel-lwey 440000 CELLS Drug Implant
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrevakinagene taroretcel-lwey 200,000 to 440,000 CELLS Intravitreal Implant
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Revakinagene Taroretcel-Lwey: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Encelto is not an eye drop or a standard injection — it's a tiny implant surgically placed inside your eye by an ophthalmologist. Inside the implant are living engineered cells tha...
  • What exactly is Encelto, and how is it different from regular eye drops or injections?
  • Yes, post-operative care is important. After your Encelto surgery, you'll use antibiotic eye drops four times a day for a week to prevent infection. You'll also use a steroid eye d...
  • What happens after the surgery — do I need to do anything at home?
📖 Read our full Revakinagene Taroretcel-Lwey guide →

🕸️ Concept Web — How Revakinagene taroretcel-lwey 440000 CELLS Drug I... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Revakinagene taroretcel-lwey 440000 CELLS Drug Implant RxCUI 2708837

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Revakinagene taroretcel 2708830
    • Revakinagene taroretcel-lwey 2708831
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Encelto 2708838
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Revakinagene taroretcel Drug Implant 2708834
    • Revakinagene taroretcel-lwey Drug Implant 2708836
    • Revakinagene taroretcel Drug Implant Product 2708833
    • Revakinagene taroretcel-lwey Drug Implant Product 2708835
    • Revakinagene taroretcel Drug Implant [Encelto] 2708841
    • Revakinagene taroretcel-lwey Drug Implant [Encelto] 2708842
    • Encelto Drug Implant Product 2708840
    • Drug Implant 657710
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Revakinagene taroretcel-lwey 440000 CELLS SCDC · 2708832
  • Revakinagene taroretcel Drug Implant SCDF · 2708834
  • Revakinagene taroretcel-lwey Drug Implant SCDFP · 2708836
  • Revakinagene taroretcel Drug Implant Product SCDG · 2708833
  • Revakinagene taroretcel-lwey Drug Implant Product SCDGP · 2708835

Brand-Name Concepts

  • Revakinagene taroretcel-lwey 440000 CELLS Drug Implant [Encelto] SBD · 2708843
  • Revakinagene taroretcel-lwey 440000 CELLS [Encelto] SBDC · 2708839
  • Revakinagene taroretcel Drug Implant [Encelto] SBDF · 2708841
  • Revakinagene taroretcel-lwey Drug Implant [Encelto] SBDFP · 2708842
  • Encelto Drug Implant Product SBDG · 2708840
  • Encelto BN · 2708838

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2708837 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
82958-0501-01 1 CAPSULE in 1 CONTAINER (82958-501-01) / 1 IMPLANT in 1 CA... ENCELTO Neurotech Pharmaceuticals, Inc. 2025-03-12
Observed labelers: Neurotech Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.